BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18077052)

  • 1. Membrane permeable peptide vectors: chemistry and functional design for the therapeutic applications.
    Futaki S
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):447. PubMed ID: 18077052
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicting cell-penetrating peptides.
    Hansen M; Kilk K; Langel U
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):572-9. PubMed ID: 18045726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein and peptide transduction, twenty years later a happy birthday.
    Prochiantz A
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):448-51. PubMed ID: 18053614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin-derived peptide carriers: mechanisms and application.
    Rennert R; Neundorf I; Beck-Sickinger AG
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):485-98. PubMed ID: 18160173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery.
    Mäe M; Langel U
    Curr Opin Pharmacol; 2006 Oct; 6(5):509-14. PubMed ID: 16860608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-penetrating peptides for drug delivery across membrane barriers.
    Foged C; Nielsen HM
    Expert Opin Drug Deliv; 2008 Jan; 5(1):105-17. PubMed ID: 18095931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intracellular and nuclear-targeted delivery of an antiandrogen drug by carrier peptides.
    Hodoniczky J; Sims CG; Best WM; Bentel JM; Wilce JA
    Biopolymers; 2008; 90(5):595-603. PubMed ID: 18351583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proline-rich, amphipathic cell-penetrating peptides.
    Pujals S; Giralt E
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):473-84. PubMed ID: 18187229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
    Deshayes S; Morris M; Heitz F; Divita G
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):537-47. PubMed ID: 18037526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular uptake mechanisms and potential therapeutic utility of peptidic cell delivery vectors: progress 2001-2006.
    Fischer PM
    Med Res Rev; 2007 Nov; 27(6):755-95. PubMed ID: 17019680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tandem ligation of multipartite peptides with cell-permeable activity.
    Eom KD; Miao Z; Yang JL; Tam JP
    J Am Chem Soc; 2003 Jan; 125(1):73-82. PubMed ID: 12515508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chances and pitfalls of cell penetrating peptides for cellular drug delivery.
    Tréhin R; Merkle HP
    Eur J Pharm Biopharm; 2004 Sep; 58(2):209-23. PubMed ID: 15296950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transduction peptides: from technology to physiology.
    Joliot A; Prochiantz A
    Nat Cell Biol; 2004 Mar; 6(3):189-96. PubMed ID: 15039791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphipathic peptides and drug delivery.
    Fernández-Carneado J; Kogan MJ; Pujals S; Giralt E
    Biopolymers; 2004; 76(2):196-203. PubMed ID: 15054899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Membrane permeable basic peptides: the potential of these peptides for the intracellular delivery of proteins and drugs].
    Futaki S
    Tanpakushitsu Kakusan Koso; 2002 Sep; 47(11):1415-9. PubMed ID: 12229209
    [No Abstract]   [Full Text] [Related]  

  • 16. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides.
    Nakase I; Takeuchi T; Tanaka G; Futaki S
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):598-607. PubMed ID: 18045727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in cell-penetrating, non-peptide molecular carriers.
    Chung SK; Maiti KK; Lee WS
    Int J Pharm; 2008 Apr; 354(1-2):16-22. PubMed ID: 17890027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organelle-targeted delivery of biological macromolecules using the protein transduction domain: potential applications for Peptide aptamer delivery into the nucleus.
    Yoshikawa T; Sugita T; Mukai Y; Yamanada N; Nagano K; Nabeshi H; Yoshioka Y; Nakagawa S; Abe Y; Kamada H; Tsunoda S; Tsutsumi Y
    J Mol Biol; 2008 Jul; 380(5):777-82. PubMed ID: 18571668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct and rapid cytosolic delivery using cell-penetrating peptides mediated by pyrenebutyrate.
    Takeuchi T; Kosuge M; Tadokoro A; Sugiura Y; Nishi M; Kawata M; Sakai N; Matile S; Futaki S
    ACS Chem Biol; 2006 Jun; 1(5):299-303. PubMed ID: 17163758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTD-mediated delivery of anti-cell death proteins/peptides and therapeutic enzymes.
    Asoh S; Ohta S
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):499-516. PubMed ID: 18093693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.